PT Unilever Indonesia Tbk (UNLRY) Fair Value & Analysis
Consumer Defensive · US · Market cap $3.8B
Analysis
PT Unilever Indonesia Tbk (UNLRY) currently trades at $1.86, while our model-based Fair Value estimate is $3.68 — implying the stock looks roughly 97.8% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
PT Unilever Indonesia Tbk manufactures, markets, and distributes consumer goods in Indonesia. The company operates in two segments: Home and Personal Care; and Foods and Refreshment. It offers soaps, detergents, dairy based foods, ice creams, cosmetic products, tea-based beverages, and fruit juices. The company provides its products under the Axe, Bango, Buavita, Cif, Citra, Clear, Clear Men, Close Up, Cornetto, Dove, Feast, Feast, Glow & Lovely, Jawara, Knorr, Lifebuoy, Lipton, Love Beauty & Planet, Lux, Magnum, Molto, Paddle Pop, Pepsodent, Pond's, Pond's Men, Populaire, Rexona, Rinso, Royco, SariWangi, Seru, Simple, St. Ives, Suave, Sunlight, Sunsilk, Superpell, TRESemmé, The Vegetarian Butcher, Unilever Professional, Vaseline Men, Viennetta, Vixal, Wall's, Wipol, Zwitsalm, and other brands. It also leases office space. PT Unilever Indonesia Tbk was founded in 1933 and is headquartered in Tangerang, Indonesia. PT Unilever Indonesia Tbk operates as a subsidiary of Unilever Indones…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.